Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lazzaro Repetto

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|May 2, 2009
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective surveyLazzaro Repetto,
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 8, 2002
[Chemotherapy in the elderly patient]Lazzaro Repetto
The Journal of Supportive Oncology|September 7, 2004
Greater risks of chemotherapy toxicity in elderly patients with cancerLazzaro Repetto
Surgical Oncology|May 29, 2007
Optimising treatment decisions for the onco-geriatric patient: the need for Comprehensive Geriatric Assessment in routine clinical practiceLazzaro Repetto
Cancer|December 24, 2003
Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphomaLodovico Balducci, Lazzaro Repetto
Recenti Progressi in Medicina|January 27, 2015
[Cancer treatment in elderly patients: evidence and clinical research]Lazzaro Repetto, Andrea Luciani
The Lancet. Oncology|June 18, 2002
A case for geriatric oncologyLazzaro Repetto, Lodovico Balducci
Anti-Cancer Drugs|October 11, 2003
The importance of prophylactic management of chemotherapy-induced neutropeniaLazzaro Repetto, Caterina Accettura
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Elderly patients have become the leading drug consumers: it's high time to properly evaluate new drugs within the real targeted populationLazzaro Repetto, Riccardo A Audisio
Tumori|July 25, 2012
"Do elderly cancer patients have different care needs compared with younger ones?"Carola Locatelli, Marcella Cicerchia, Lazzaro Repetto
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|May 2, 2009
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective surveyLazzaro Repetto,
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 8, 2002
[Chemotherapy in the elderly patient]Lazzaro Repetto
The Journal of Supportive Oncology|September 7, 2004
Greater risks of chemotherapy toxicity in elderly patients with cancerLazzaro Repetto
Surgical Oncology|May 29, 2007
Optimising treatment decisions for the onco-geriatric patient: the need for Comprehensive Geriatric Assessment in routine clinical practiceLazzaro Repetto
Cancer|December 24, 2003
Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphomaLodovico Balducci, Lazzaro Repetto
Recenti Progressi in Medicina|January 27, 2015
[Cancer treatment in elderly patients: evidence and clinical research]Lazzaro Repetto, Andrea Luciani
The Lancet. Oncology|June 18, 2002
A case for geriatric oncologyLazzaro Repetto, Lodovico Balducci
Anti-Cancer Drugs|October 11, 2003
The importance of prophylactic management of chemotherapy-induced neutropeniaLazzaro Repetto, Caterina Accettura
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Elderly patients have become the leading drug consumers: it's high time to properly evaluate new drugs within the real targeted populationLazzaro Repetto, Riccardo A Audisio
Tumori|July 25, 2012
"Do elderly cancer patients have different care needs compared with younger ones?"Carola Locatelli, Marcella Cicerchia, Lazzaro Repetto
Pageof 4